02 Nov 2011 | Nature Medicine Article Comments on Population Diagnostics’ Autism DNA Test Development

Nature Medicine – November 2, 2011 – journal article on autism Dx testing discusses Population Diagnostics’ test development for pre-symptomatic diagnosis in newborns. Early detection is advocated by clinicians and researchers, “The earlier the diagnosis, the earlier you can start some type of interventional therapy,” said Dr. Stephen Scherer at Toronto's Hospital for Sick Children.

Full article

15 Sep 2011 | Population Diagnostics Appoints Sir Walter Bodmer to Scientific Advisory Board

Press Release – Melville, NY – September 15, 2011 – Population Diagnostics, Inc. (PDx), a private company with a novel approach for systematically uncovering the genetic causes of disease as well as the genetic basis of drug efficacy and safety, announced today the appointment of Sir Walter Bodmer to its Scientific Advisory Board.

Press release

02 Nov 2010 | Population Diagnostics Awarded Two Federal Grants to Support Its Autism and Parkinson’s Disease Programs

Grant Awards – November 2, 2010 – Population Diagnostics was awarded two federal grants totaling $489,000 under a provision of the Patient Protection and Affordable Care Act enacted in 2010.  The grant applications, which were reviewed and approved by the Department of Health and Human Services (HHS), are entitled:

"Development of an Autism Early Detection Genetic Test"

"A Rational & Systematic Approach to Parkinson's Disease ("PD") Drug Therapy Development"

See the complete list of awards. 

12 Sep 2010 | Population Diagnostics Submits Public Comments to the FDA Regarding Laboratory-Developed Test (LDT) Regulation

Public comments (Docket ID FDA-2010-N-0274) – September 12, 2010 – Population Diagnostics submitted comments to the FDA in response to the July 19-20 meeting held for public input on a proposal to increase oversight of LDTs, which are currently regulated by the Clinical Laboratory Improvement Amendments (CLIA). 

See the PDx comments letter.

05 Jul 2010 | Modern Approaches to the Study of the Genetics of Autism

Event – Jerusalem, Israel – July 5-6, 2010 – icare4autism’s 2010 International Autism Conference.  Dr. Eli Hatchwell, Population Diagnostics CSO and Associate Professor at SUNY Stony Brook, was an invited speaker and chaired the Genetics Section at Icare4autism’s 2010 International Autism Conference.

Meeting information

17 May 2010 | Population Diagnostics Receives Grant from National Institutes of Health for Parkinson’s Disease Study

Press Release –Melville, NY– May 17, 2010 – Population Diagnostics, Inc. (PDx), a private company with a novel approach to revealing the genetic causes of disease and predicting drug response, announced today it has been awarded a federal grant to identify the genetic causes of Parkinson’s Disease. Funded by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health, the project is being led by Eli Hatchwell, MD, PhD, an Associate Professor at Stony Brook University Medical Center and a co-founder of PDx.

Press release

05 Feb 2010 | CNV Studies in Autism and other Neurological Disorders

Event – San Francisco, CA – February 5, 2010 – CHI’s 17th International Molecular Medicine Tri-Conference 2010.  CEO Jim Chinitz, invited speaker in Diagnostics Channel session:  Personalized Diagnostics:  “Under the Hood” Technologies for Molecular Diagnostics, Innovative Diagnostics for Personalized Medicine

Meeting information

13 Jan 2010 | Population Diagnostics Appoints Dr. Peggy Eis as Chief Technology Officer

Press Release – Melville, NY – January 13, 2010 – Population Diagnostics, Inc. (PDx), a private company developing a new generation of molecular diagnostic and personalized medicine companion tests, announced today the appointment of Dr. Peggy Eis as Chief Technology Officer

Press release

02 Nov 2009 | Cоpy Number Variation (CNV) Analysis and Causative Mutations  

Event – New Orleans, LA – November 2, 2009 – 53rd Annual American Osteopathic Association (AOA) Research Conference.  CEO Jim Chinitz, invited speaker in session “The Translation of Genomic Science into Osteopathic Clinical Practice and Research”

Meeting information

17 Jan 2008 | Population Diagnostics Wins Award in New York State Technology Innovation Competition

Press Release – Melville, NY – June 17, 2008 – Population Diagnostics, Inc. (PDx) announced today that it has won a technology innovation awarded by NY Loves Bio… sponsoring PDx in the New York Pavilion at the BIO 2008 International Conference

Press release

04 Apr 2008 | World Autism Awareness Day interview with Population Diagnostics Cofounder
Dr. Eli Hatchwell

CNN International (London Studio) – April 4, 2008 – Anchorwoman Rosemary Church

Full story

19 Mar 2008 | Researchers Identify Copy Number Variation Linked to Autism by Subtracting
‘Normal’ Variation

GenomeWeb Daily News – March 19, 2008 – Article featuring Population Diagnostics cofounder Dr. Hatchwell’s discovery of autism gene Contactin 4 (CNTN4) [Journal of Medical Genetics publication] and the company’s normal variation core technology for discovery of disease genes

Full story 

19 Mar 2008 | Population Diagnostics Mutation Discovery Technology is Used to Find Autism Gene

Newday– March 19, 2008 – Population Diagnostics, Inc. announced today that its mutation discovery technology was used to reveal genetic biomarkers associated with autism

Full story

19 Mar 2008 | Gene for Brain Connections Linked with Autism

Reuters – March 19, 2008 – Health and Science article featuring Population Diagnostics cofounder Dr. Hatchwell’s discovery of autism gene Contactin 4 (CNTN4) [Journal of Medical Genetics paper]; cites Population Diagnostics is developing early detection tests for autism and other genetic diseases

Full story